News

An mRNA-based flu vaccine has the potential advantage to more precisely match circulating strains, support rapid response in a future influenza pandemic, and pave the way for COVID-19 combination ...
The multicomponent mRNA-1083 vaccine elicited noninferior immune responses in adult patients when compared with coadministered influenza and COVID-19 vaccines.
The virus has not yet evolved to spread efficiently between people. Excellent vaccine technology exists, but the government ...
The inaccurate rumours refer to a study looking at excess deaths during the pandemic in the German city of Frankfurt am Main.
FDA vaccine head Vinay Prasad restricted Moderna and Novavax COVID vaccines to high-risk groups, overriding staff advice amid ...
Recent developments that have caused concern include removing all members of a scientific committee that advises the Centers for Disease Control and Prevention (CDC) on vaccines and replacing them ...
A key advisory group vows to base decisions on evidence, boost confidence in vaccines and protect health. Experts fear the opposite is happening.
Following its acquisition by Supernus Pharmaceuticals, Sage Therapeutics has let go of all of its remaining workforce, which ...
The US Advisory Committee on Immunization Practices voted in June to stop recommending certain kinds of flu vaccines, a ...
A top official at the Food and Drug Administration recently overruled government scientists on the availability of two ...
The African Pharmaceutical Market is projected to grow at an impressive CAGR of 6-8% by 2029, driven by a booming population, ...
Vaccine supply shortage comes at a bad time, as African countries make headway with their outbreaks and have seen good uptake ...